PIM1 and acute myeloid leukemia: Murine models of AML have demonstrated that a high tumor burden persists in spite of improved survival with Pim inhibition with rapid relapse on drug withdrawal12 suggesting that disease control, rather than significant tumor killing, is the realistic effect of Pims as single agents.